| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |